Page last updated: 2024-10-24

busulfan and Digestive System Disorders

busulfan has been researched along with Digestive System Disorders in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Busulfan is a major component of chemotherapy conditioning in hematopoietic cell transplantation (HCT)."5.51Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative/reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient. ( Bezinelli, LM; Carvalho, DLC; Corrêa, L; da Silva, CC; Eduardo, FP; Ferreira, MH; Gobbi, M; Hamerschlak, N; Rosin, FCP, 2019)
"Busulfan is a major component of chemotherapy conditioning in hematopoietic cell transplantation (HCT)."1.51Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative/reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient. ( Bezinelli, LM; Carvalho, DLC; Corrêa, L; da Silva, CC; Eduardo, FP; Ferreira, MH; Gobbi, M; Hamerschlak, N; Rosin, FCP, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eduardo, FP1
Bezinelli, LM1
Gobbi, M1
Rosin, FCP1
Carvalho, DLC1
Ferreira, MH1
da Silva, CC1
Hamerschlak, N1
Corrêa, L1
Baronciani, D1
Rambaldi, A1
Iori, AP1
Di Bartolomeo, P1
Pilo, F1
Pettinau, M1
Depau, C1
Mico, C1
Santarone, S1
Angelucci, E1

Trials

1 trial available for busulfan and Digestive System Disorders

ArticleYear
Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients.
    American journal of hematology, 2008, Volume: 83, Issue:9

    Topics: Adolescent; Adult; Aged; Busulfan; Chemical and Drug Induced Liver Injury; Combined Modality Therapy

2008

Other Studies

1 other study available for busulfan and Digestive System Disorders

ArticleYear
Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative/reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2019, Volume: 27, Issue:3

    Topics: Adult; Aged; Busulfan; Digestive System Diseases; Female; Graft vs Host Disease; Hematopoietic Stem

2019